Could a daily pill replace monthly shots for acromegaly?
NCT ID NCT04837040
First seen Jan 18, 2026 · Last updated May 21, 2026 · Updated 15 times
Summary
This study tests an oral drug called paltusotine for people with acromegaly, a condition where the body makes too much growth hormone. Participants who were stable on standard injectable treatments either switched to paltusotine or a placebo. The goal is to see if the pill can keep hormone levels normal and avoid the need for injections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACROMEGALY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Crinetics Study Site
Los Angeles, California, 90048, United States
-
Crinetics Study Site
Torrance, California, 90502, United States
-
Crinetics Study Site
Baltimore, Maryland, 21205, United States
-
Crinetics Study Site
Boston, Massachusetts, 02114, United States
-
Crinetics Study Site
Philadelphia, Pennsylvania, 19104, United States
-
Crinetics Study Site
Pittsburgh, Pennsylvania, 15212, United States
-
Crinetics Study Site
Nashville, Tennessee, 37203, United States
-
Crinetics Study Site
CABA, Buenos Aires, C1012AAR, Argentina
-
Crinetics Study Site
Ciudad Autonoma de Buenos Aire, Buenos Aires, C1405BCH, Argentina
-
Crinetics Study Site
Córdoba, X5000, Argentina
-
Crinetics Study Site
Ghent, 9000, Belgium
-
Crinetics Study Site
Fortaleza, Ceará, 60430-275, Brazil
-
Crinetics Study Site
Curitiba, Paraná, 80030-110, Brazil
-
Crinetics Study Site
Porto Alegre, Rio Grande do Sul, 90410-000, Brazil
-
Crinetics Study Site
Rio de Janeiro, 20231-092, Brazil
-
Crinetics Study Site
Rio de Janeiro, 21941-913, Brazil
-
Crinetics Study Site
Sofia, 1431, Bulgaria
-
Crinetics Study Site
Bron, 69677, France
-
Crinetics Study Site
Pessac, 33604, France
-
Crinetics Study Site
Budapest, 1083, Hungary
-
Crinetics Study Site
Pécs, 7624, Hungary
-
Crinetics Study Site
Beersheba, 8410101, Israel
-
Crinetics Study Site
Petah Tikva, 4941480, Israel
-
Crinetics Study Site
Roma, 00168, Italy
-
Crinetics Study Site
San Isidro, Lima region, 15023, Peru
-
Crinetics Study Site
Bydgoszcz, 85-605, Poland
-
Crinetics Study Site
Poznan, 60-355, Poland
-
Crinetics Study Site
Kemerovo, Kemerovo Oblast, 650066, Russia
-
Crinetics Study Site
Novosibirsk, Novosibirsk Oblast, 630005, Russia
-
Crinetics Study Site
Novosibirsk, Novosibirsk Oblast, 630087, Russia
-
Crinetics Study Site
Samara, Samara Oblast, 443041, Russia
-
Crinetics Study Site
Kazan', Tatarstan Republic, 420097, Russia
-
Crinetics Study Site
Moscow, 117186, Russia
-
Crinetics Study Site
Moscow, 119435, Russia
-
Crinetics Study Site
Moscow, 125008, Russia
-
Crinetics Study Site
Belgrade, 11000, Serbia
-
Crinetics Study Site
Sheffield, South Yorkshire, S102JF, United Kingdom
-
Crinetics Study Site
Coventry, West Midlands, CV2 2DX, United Kingdom
-
Crinetics Study Site
London, W12 0HS, United Kingdom
Conditions
Explore the condition pages connected to this study.